![](/images/graphics-bg.png)
Screening for vancomycin-resistant and intermediate S. aureus by the e-test from selected hospitals of Bethlehem and Jerusalem Districts
Other Title(s)
الكشف عن حساسية البكتيريا العنقودية (Staphlococcus aureus) (متوسطة-و مقاومة) للفنكوميسين بغستخدام فحص E-Test (إيبسيلوميتر) في المستشفيات المختارة في محافظتي بيت لحم-الخليل
Joint Authors
Hazbun, Nadir
Duiq, Rita
Qattan, Randah
Hindiyah, Musa
Source
Issue
Vol. 2011, Issue 30 (31 Dec. 2011), pp.20-29, 10 p.
Publisher
Bethlehem University Office of the Deanship of Research
Publication Date
2011-12-31
Country of Publication
Palestine (West Bank)
No. of Pages
10
Main Subjects
Abstract EN
The glycopeptide antibiotic vancomycin is frequently used as the drug of choice for the treatment of infections caused by methicillin-resistant Staphylococcus aureus (MRSA).
MRSA has been reported to cause severe life threatening infections that mandate the utilization of aggressive antimicrobial therapy such as the glycopeptides to clear these infections.
However, the increase utilization of glycopeptides and in particular vancomycin has lead to the emergence of vancomycin-intermediate S.
aureus (VISA) and vancomycin-resistant S.
aureus (VRSA).
The present study was carried out to screen for the presence of VISA and VRSA in the hospitals of Bethlehem and East Jerusalem districts.
A total of 190 S.
aureus isolates from blood culture and abscesses were subjected to MIC testing using the E-test for vancomycin with concentration 0.016-256 μg/ml.
All of the 190 S.
aureus isolates were found to be sensitive to vancomycin according to the Clinical and Laboratory Standard Institute (CLSI) M40-A antimicrobial guidelines where vancomycin MIC ≤ 2μg/ml is considered as susceptible, MIC = 4-8 μg/ml is intermediate and MIC ≥ 16 μg/ml is resistant.
Of the 190 S.
aureus, 4.2% (8/190) were sensitive to vancomycin at a concentration ≤ 2 μg/ml, 40.5% (77/190) with a concentration ≤ 1.5 μg/ml, 46.8% (89/190) with a concentration ≤ 1 μg/ml, and 8.4% (16/190) with a concentration ≤ 0.5 μg/ml.
American Psychological Association (APA)
Duiq, Rita& Hazbun, Nadir& Qattan, Randah& Hindiyah, Musa. 2011. Screening for vancomycin-resistant and intermediate S. aureus by the e-test from selected hospitals of Bethlehem and Jerusalem Districts. Bethlehem University Journal،Vol. 2011, no. 30, pp.20-29.
https://search.emarefa.net/detail/BIM-629328
Modern Language Association (MLA)
Duiq, Rita…[et al.]. Screening for vancomycin-resistant and intermediate S. aureus by the e-test from selected hospitals of Bethlehem and Jerusalem Districts. Bethlehem University Journal No. 30 (2011), pp.20-29.
https://search.emarefa.net/detail/BIM-629328
American Medical Association (AMA)
Duiq, Rita& Hazbun, Nadir& Qattan, Randah& Hindiyah, Musa. Screening for vancomycin-resistant and intermediate S. aureus by the e-test from selected hospitals of Bethlehem and Jerusalem Districts. Bethlehem University Journal. 2011. Vol. 2011, no. 30, pp.20-29.
https://search.emarefa.net/detail/BIM-629328
Data Type
Journal Articles
Language
English
Notes
Includes bibliographical references : p. 27-28
Record ID
BIM-629328